The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis

被引:1
|
作者
Paez, Diana [1 ]
Giammarile, Francesco [1 ]
Brink, Anita [1 ]
Garcia-Perez, Osvaldo [2 ]
Estrada-Lobato, Enrique [1 ,3 ]
机构
[1] Int Atom Energy Agcy Vienna, Dept Nucl Sci & Applicat, Div Human Hlth, Nucl Med & Diagnost Imaging Sect, Vienna, Austria
[2] NCI, Dept Nucl Med, Mexico City, Mexico
[3] Int Atom Energy Agcy IAEA, Nucl Med & Diagnost Imaging Sect, Vienna, Austria
关键词
SPINE; OSTEOMYELITIS; INFECTIONS; TOOL;
D O I
10.1053/j.semnuclmed.2024.04.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Spondylodiscitis, characterized by inflammation of the intervertebral disc and adjacent vertebral bodies, presents a diagnostic challenge due to its nonspecific clinical manifestations and variable imaging findings. This review examines the role of PET-CT with FDG, in the evaluation of spondylodiscitis, focusing on its utility in diagnosis, assessment of disease extent, treatment response monitoring, and prognostication. FDG PET-CT, by combining metabolic and anatomical imaging modalities, offers superior sensitivity and specificity compared to conventional imaging techniques in detecting infectious foci, distinguishing between infection and post-treatment changes, and identifying occult sources of infection. Additionally, FDG PET-CT facilitates the localization of infection, aiding in targeted biopsy and guiding surgical intervention. Moreover, quantitative PET parameters, such as standardized uptake values (SUVs), hold promise for predicting treatment response and prognosis. Despite its advantages, FDG PET-CT has limitations, including false-positive results in the setting of inflammation and limited availability in resourceconstrained settings. Collaborative efforts between radiologists, nuclear medicine specialists, infectious disease specialists, and spine surgeons are essential to optimize the role of FDG PET-CT in the multidisciplinary management of spondylodiscitis. Further research is warranted to elucidate the cost-effectiveness and clinical impact of FDG PET-CT in this challenging clinical entity. Semin Nucl Med 54:409-414 (c) 2024 Elsevier Inc. All rights reserved.
引用
收藏
页码:409 / 414
页数:6
相关论文
共 50 条
  • [11] Fluorodeoxyglucose positron emission tomography (18F-FDG PET)-computed tomography (CT) in the initial staging of bladder cancer: a single institution experience
    Shahait, Mohammed
    Abu-Hijlih, Ramiz
    Farkouh, Ala'a
    Obeidat, Shahed
    Salah, Samer
    Abdlkadir, Ahmed Saad
    Al-Ibraheem, Akram
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2023, 35 (01)
  • [12] The role of 18F-FDG positron emission tomography for the diagnosis of vasculitides
    Braun, J.
    Baraliakos, X.
    Fruth, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (05) : S108 - S114
  • [13] Macrophage subtypes and 18-fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging of symptomatic carotid and femoral artery plaques
    Shaikh, S.
    Wilson, H.
    Welch, A.
    Murray, A.
    McKiddie, F.
    Brittenden, J.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 2 - 3
  • [14] Lymphomatous involvement of the gastrointestinal tract:: Evaluation by positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG).
    Phongkitkarun, S
    Varavithya, V
    Kazama, T
    Faria, SC
    Mar, M
    Podoloff, DA
    Macapinlac, HA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 83P - 83P
  • [15] Characteristics of malignant thyroid lesions on [18F] fluorodeoxyglucose (FDG)-Positron emission tomography (PET)/Computed tomography (CT)
    Nasr, Hatem
    Farghaly, Hussein
    Alqarni, Abdullah
    Al-Salem, Seham
    Sayed, Mohamed
    EUROPEAN JOURNAL OF RADIOLOGY OPEN, 2021, 8
  • [16] Characteristics of malignant thyroid lesions on [18F]Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT)
    Nasr, H.
    Farghaly, H.
    Alqarni, A.
    Al-Salem, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S322 - S323
  • [17] Dual time point 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
    Yamagishi, Yoji
    Koiwai, Tomomi
    Yamasaki, Tamio
    Einama, Takahiro
    Fukumura, Makiko
    Hiratsuka, Miyuki
    Kono, Takako
    Hayashi, Katsumi
    Ishida, Jiro
    Ueno, Hideki
    Tsuda, Hitoshi
    BMC CANCER, 2019, 19 (01)
  • [18] Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with pancreatic neuroendocrine tumors
    Matsumoto, Takashi
    Okabe, Hirohisa
    Yamashita, Yo-ichi
    Yusa, Toshihiko
    Itoyama, Rumi
    Nakao, Yosuke
    Yamao, Takanobu
    Umzaki, Naoki
    Tsukamoto, Masayo
    Kitano, Yuki
    Miyata, Tatsunori
    Arima, Kota
    Nitta, Hidetoshi
    Hayashi, Hiromitsu
    Imai, Katsunori
    Chikamoto, Akira
    Baba, Hideo
    SURGERY TODAY, 2019, 49 (01) : 21 - 26
  • [19] Dual time point 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
    Yoji YAMAGISHI
    Tomomi KOIWAI
    Tamio YAMASAKI
    Takahiro EINAMA
    Makiko FUKUMURA
    Miyuki HIRATSUKA
    Takako KONO
    Katsumi HAYASHI
    Jiro ISHIDA
    Hideki UENO
    Hitoshi TSUDA
    BMC Cancer, 19
  • [20] Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with pancreatic neuroendocrine tumors
    Takashi Matsumoto
    Hirohisa Okabe
    Yo-ichi Yamashita
    Toshihiko Yusa
    Rumi Itoyama
    Yosuke Nakao
    Takanobu Yamao
    Naoki Umzaki
    Masayo Tsukamoto
    Yuki Kitano
    Tatsunori Miyata
    Kota Arima
    Hidetoshi Nitta
    Hiromitsu Hayashi
    Katsunori Imai
    Akira Chikamoto
    Hideo Baba
    Surgery Today, 2019, 49 : 21 - 26